Ceftriaxone IM Dosing for 32.26 kg Patient
For a patient weighing 32.26 kg, administer ceftriaxone 50-75 mg/kg once daily intramuscularly, which equals 1,613-2,420 mg (approximately 1.6-2.4 grams), not to exceed 2 grams total daily dose. 1
Dosing Calculation
For this 32.26 kg pediatric patient:
- Standard dose range: 50-75 mg/kg/day
- Calculated dose: 1,613 mg to 2,420 mg
- Practical dose: 2 grams IM once daily (maximum pediatric dose for most infections)
The FDA-approved labeling for Rocephin specifies that pediatric patients should receive 50-75 mg/kg given once daily (or in equally divided doses twice daily) for skin and skin structure infections, with a maximum total daily dose not exceeding 2 grams 1. This dosing applies to serious miscellaneous infections other than meningitis.
Indication-Specific Considerations
The exact dose within this range depends on the indication:
Acute otitis media: Single IM dose of 50 mg/kg (not to exceed 1 gram) - would be approximately 1,600 mg or 1 gram for this patient 1
Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours or once daily, maximum 2 grams daily - use 2 grams once daily for this patient 1
Meningitis: 100 mg/kg/day (not to exceed 4 grams) - would be approximately 3.2 grams for this patient, but this requires IV administration 1
Administration Guidelines
Intramuscular injection technique 1:
- Inject well within the body of a relatively large muscle
- Aspirate to avoid unintentional injection into a blood vessel
- After reconstitution, each 1 mL contains approximately 250 mg or 350 mg of ceftriaxone depending on diluent volume
For a 2-gram dose, you would use the 2-gram vial reconstituted with 7.2 mL diluent to achieve 250 mg/mL concentration, or 4.2 mL diluent for 350 mg/mL concentration 1.
Important Safety Considerations
Critical contraindications and warnings 1:
- Do not use in hyperbilirubinemic neonates, especially premature infants
- Contraindicated in neonates ≤28 days requiring calcium-containing IV solutions
- This 32.26 kg patient is well beyond the neonatal period, so these restrictions do not apply
Duration of therapy: Generally continue for at least 2 days after signs and symptoms of infection have disappeared, with usual duration of 4-14 days depending on infection type 1. For Streptococcus pyogenes infections, continue for at least 10 days.
Clinical Context from Guidelines
The pediatric dosing recommendations are consistent across multiple infectious disease guidelines 2, 3. For infants and children, ceftriaxone 50-75 mg/kg/day divided every 12-24 hours (maximum 2 grams daily for non-CNS infections) represents the standard approach for serious bacterial infections.
For this specific patient at 32.26 kg, the practical recommendation is 2 grams IM once daily, which falls within the FDA-approved range and maximizes efficacy while respecting the safety ceiling of 2 grams for non-meningeal infections.